MAPS

Lumanity and Sorcero Announce Partnership to Deliver AI-Powered Medical Strategy and Communications

Retrieved on: 
Thursday, March 21, 2024
Health literacy, Organization, Medicine, Learning, Partnership, Education, Patient, PLS, Communication, AI, Data, Ecosystem, MAPS, Medical device

WASHINGTON, March 21, 2024 /PRNewswire-PRWeb/ -- Lumanity, a global life sciences strategic services partner, and Sorcero, a leading provider of advanced AI solutions purpose-built for life sciences, today announced a partnership to deliver AI-powered medical strategy and communications by harnessing a number of AI-enabled solutions. Through the partnership, medical affairs can generate exponentially more insights from their data to drive decision-making, and leverage auto-generated Plain Language Summaries (PLS) to deliver more efficient and effective medical communications.

Key Points: 
  • Through the partnership, medical affairs can generate exponentially more insights from their data to drive decision-making, and leverage auto-generated Plain Language Summaries (PLS) to deliver more efficient and effective medical communications.
  • Through the partnership, medical affairs can generate exponentially more insights from their data to drive decision-making, and leverage auto-generated Plain Language Summaries to deliver more efficient and effective medical communications.
  • This discipline now involves insight mapping, managing evidence generation, transforming and personalizing physician engagement, and education - all while integrating patients' needs and perspectives," said Michael Parisi, Global Practice Lead, Medical Strategy and Communications at Lumanity.
  • To power this combined solution, Lumanity will tap into Sorcero's platform and its application, Sorcero MIM™(Medical Insights Management), which leverages proprietary, medically-tuned AI.

Summit Venture Studio Licenses Medication Administration Protection System to Enhance Medication Safety

Retrieved on: 
Tuesday, March 19, 2024
Medicine, PMID, Risk, EMR, Patient, Internet, Pharming, Research, Artificial intelligence, Software, Death, HMH, Medical error, Patient safety, Machine learning, LEHI, MAPS, Health, Approximation error, BMJ, Nursing

LEHI, Utah, March 19, 2024 /PRNewswire-PRWeb/ -- Summit Venture Studio is excited to announce its license and commercialization of the clinical surveillance tool MAPS (Medication Administration Protection System). MAPS is a pioneering software, designed by Houston Methodist, that enhances medication safety in the health care setting.

Key Points: 
  • Summit Venture Studio is excited to announce its license and commercialization of the clinical surveillance tool MAPS (Medication Administration Protection System).
  • MAPS is a pioneering software, designed by Houston Methodist, that enhances medication safety in the health care setting.
  • LEHI, Utah, March 19, 2024 /PRNewswire-PRWeb/ -- Summit Venture Studio is excited to announce its license and commercialization of the clinical surveillance tool MAPS (Medication Administration Protection System).
  • MAPS is a pioneering software, designed by Houston Methodist, that enhances medication safety in the health care setting.

Anju to Exhibit at MAPS 2024 in Puerto Rico

Retrieved on: 
Tuesday, March 19, 2024
Pharmacovigilance, Patient, SVP, Organization, MAPS, Anju

FORT LAUDERDALE, Fla., March 19, 2024 /PRNewswire/ -- Anju, a global pioneer in tailored life science solutions, is proud to announce its participation as an exhibitor at the upcoming Medical Affairs Professional Society (MAPS) 2024 conference in Puerto Rico.

Key Points: 
  • FORT LAUDERDALE, Fla., March 19, 2024 /PRNewswire/ -- Anju, a global pioneer in tailored life science solutions, is proud to announce its participation as an exhibitor at the upcoming Medical Affairs Professional Society (MAPS) 2024 conference in Puerto Rico.
  • "At Anju, we are dedicated to delivering innovative solutions that empower our clients to succeed in an ever-evolving regulatory landscape," said Reed McLaughlin, SVP of Sales at Anju.
  • "MAPS 2024 provides an ideal platform for us to connect with industry leaders, share insights, and showcase our latest offerings."
  • Don't miss the opportunity to visit Anju's booth #316 at MAPS 2024 and discover how Anju's innovative solutions can help take your organization to the next level.

Muslim Association Puget Sound Launches Pathway to Tech Project with Support from Senator Patty Murray

Retrieved on: 
Thursday, March 14, 2024
Congress, Education, Student, Certification, Pathway, PAT, MAPS, Nursing

REDMOND, Wash., March 14, 2024 /PRNewswire/ -- The Muslim Association Puget Sound (MAPS) is proud to announce the launch of the Pathway to Tech (PAT) Project, an initiative aimed at fostering opportunities in STEM careers and technical education.

Key Points: 
  • REDMOND, Wash., March 14, 2024 /PRNewswire/ -- The Muslim Association Puget Sound (MAPS) is proud to announce the launch of the Pathway to Tech (PAT) Project, an initiative aimed at fostering opportunities in STEM careers and technical education.
  • The $850,000 PAT Project is set to bridge the gap between underrepresented communities and the burgeoning tech industry.
  • In collaboration with Congressional sponsor, Senator Patty Murray, the PAT Project seeks to equip individuals with the necessary skills and knowledge to thrive in technology-driven fields.
  • The PAT Project addresses the critical shortage of skilled professionals in the tech industry by providing comprehensive education and career support.

Zimperium Takes Home the Gold in the 2024 Globee® Awards for Cybersecurity

Retrieved on: 
Thursday, March 14, 2024
MTD, Glass, Mobile security, Risk management, MAPS, Mobile phone

DALLAS, March 14, 2024 /PRNewswire/ -- Zimperium , the only mobile-first security platform for mobile devices and mobile apps, announced today that it has been honored as a Gold Globee winner in both Mobile Security and Mobile Application Security in the 20th Annual 2024 Globee Cybersecurity Awards.

Key Points: 
  • DALLAS, March 14, 2024 /PRNewswire/ -- Zimperium , the only mobile-first security platform for mobile devices and mobile apps, announced today that it has been honored as a Gold Globee winner in both Mobile Security and Mobile Application Security in the 20th Annual 2024 Globee Cybersecurity Awards.
  • The Globee Cybersecurity Awards spotlight the achievements of companies and individuals excelling in risk management, threat detection, cloud security, data privacy, and beyond.
  • "Congratulations to the 2024 victors for their pivotal role in fortifying our digital world," says San Madan, President of Globee Awards.
  • "We believe this recognition from Globee Awards further validates our commitment to our customers and their mobile security needs."

MAPS Provides Psychedelic Crisis Assessment and Intervention Training to Denver’s First Responders

Retrieved on: 
Monday, March 11, 2024
Psilocybin, SAN, Mental health, County, MAPS, Quality, Education, FDA, City, Intervention, Curriculum, Risk, Safety, Health, Medicine, Knowledge, LPC, Law enforcement, Psychiatry, Public, Nursing

MAPS uses its over 30 years of experience in the psychedelic space to offer a gold-standard training program.

Key Points: 
  • MAPS uses its over 30 years of experience in the psychedelic space to offer a gold-standard training program.
  • MAPS looks to share this training with other interested jurisdictions.
  • SAN JOSE, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) has partnered with the City and County of Denver to provide comprehensive training on psychedelic crisis assessment and intervention to the city’s first responders.
  • MAPS’ training aims to enhance the knowledge, attitudes, and skills of first responders to quickly recognize and effectively respond to emotional and behavioral crisis incidents involving psilocybin and other psychedelics.

Beckley Academy Publishes First Open-Source Learning Framework to Advance Psychedelic-Assisted Therapy Training Standards

Retrieved on: 
Tuesday, February 27, 2024
Psilocybin, MAPS, APPA, Risk, MDMA, Business, Organization, Ketamine, PAT, Publication, Research, Nursing

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Beckley Academy , the learning studio that prepares and trains practitioners to provide psychedelic-assisted therapy (PAT) with Ketamine, Psilocybin, and MDMA, announced today the open-source publication of its research: A Psychedelic-Assisted Therapy Learning Framework .

Key Points: 
  • NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Beckley Academy , the learning studio that prepares and trains practitioners to provide psychedelic-assisted therapy (PAT) with Ketamine, Psilocybin, and MDMA, announced today the open-source publication of its research: A Psychedelic-Assisted Therapy Learning Framework .
  • This industry-first learning framework will serve as a much-needed foundation to advance national training standards for clinicians to provide ethical and effective psychedelic-assisted therapy.
  • Currently, no national training standards or certifications exist for psychedelic practitioners, though many organizations have independently created training programs, practice guidelines, and codes of ethics.
  • Beckley Academy co-founding team members Deborah Gardner and Shirelle Noble recognized the opportunity to analyze existing publications and create a unified framework.

Psychedelic Science 2025 – the Fifth and Largest Psychedelic Conference in History – Announced for June 16-20 2025 in Denver, Colorado

Retrieved on: 
Tuesday, February 13, 2024
SAN, MAPS, Research, Culture, Colorado Convention Center, Spirituality, Conference, Safety, History, Death, Policy, Energy, Medicine, PTSD, Science, Trauma, Movement, Former, Psychedelic drug, Psychiatry, Cancer, Nightclub

Psychedelic Science 2023, held this past June, boasted a record-breaking 22,000+ attendees -- 12,500 in-person and over 10,000 online through The Virtual Trip. Colorado Governor Jared Polis, Former Governor of Texas and US Secretary of Energy Rick Perry, Michael Pollan, Aaron Rodgers, and Melissa Etheridge were just a few of the speakers. The distinguished Dr. Roland Griffiths, professor of behavioral science and psychiatry and a pioneer in the advancement of psychedelic research, was also honored at the largest dinner event in the history of the Colorado Convention Center in one of his last public appearances before his death from cancer in October.

Key Points: 
  • SAN JOSE, Calif. , Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies ( MAPS ) has announced that the Psychedelic Science 2025 Conference will convene in the city of Denver June 16–20, 2025, at the Colorado Convention Center.
  • This is the fifth edition of the Psychedelic Science conference series, hosted by MAPS.
  • Programming will explore the full spectrum of psychedelics, including science, medicine, policy, business, spirituality, and culture.
  • Psychedelic Science 2023, held this past June, boasted a record-breaking 22,000+ attendees -- 12,500 in-person and over 10,000 online through The Virtual Trip .

Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video

Retrieved on: 
Monday, February 12, 2024
Health Canada, MAPS, FDA, Food, FRA, HPLC, GMP, PDUFA, MDMA, Safety, Therapy, Lycus, PTSD, NDA, Chromatography, Pharmaceutical industry

Additionally, Optimi is pleased to unveil a six-minute video showcasing its end-to-end GMP MDMA encapsulation and production process.

Key Points: 
  • Additionally, Optimi is pleased to unveil a six-minute video showcasing its end-to-end GMP MDMA encapsulation and production process.
  • The FDA's priority review designation underscores the significance of this potential breakthrough in providing effective treatment options for those impacted by this debilitating condition.
  • Bill Ciprick, CEO of Optimi Health, stated, "We commend Lykos Therapeutics and MAPS founder, Rick Doblin, for their unwavering dedication to advancing innovative therapies for PTSD.
  • Stevens stated, "The ability to showcase our GMP MDMA production process is a testament to our commitment to excellence and transparency.

MAPS Congratulates Lykos Therapeutics on Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSD

Retrieved on: 
Saturday, February 10, 2024
NDA, SAN, Lycus, FDA, Food, Therapy, MAPS, Safety, PDUFA, New Drug Application, PTSD, Research, Pharmaceutical industry

"Thirty-eight years ago, one of my primary motivations for founding MAPS was to carve a path for psychedelic-assisted therapies to become FDA-approved treatments.

Key Points: 
  • "Thirty-eight years ago, one of my primary motivations for founding MAPS was to carve a path for psychedelic-assisted therapies to become FDA-approved treatments.
  • We hope that potential FDA approval of MDMA-assisted therapy for PTSD is only the first of many psychedelic-assisted therapies that become available by prescription."
  • Neither MDMA-assisted therapy for PTSD, nor any other psychedelic-assisted therapy, has been established for the treatment of any mental health condition.
  • The safety and efficacy of MDMA-assisted therapy have not been established for the treatment of PTSD.